Mr Matthew Ellis
Chairman of the Board
Matthew is a founding member of Robey Warshaw, a leading financial advisory firm. In recent years, Matthew has worked on some of the most high profile merger and acquisitions in the UK, including AstraZeneca / Pfizer and BG / Shell, and was listed by Financial News in their “40 under 40 rising stars” list in 2014. Before that, Matthew spent a number of years at Goldman Sachs and Merrill Lynch. Matthew joined the Board of Trustees in March 2016. Matthew has also fundraised for the Prostate Cancer Research Centre recently, including a sponsored climb of Mont Blanc and the London Marathon.
Mr Timothy Bruno Schroder
Timothy Schroder is a curator and lecturer. He has spent most of his career in the museum sector in the States and the UK and has published extensively in the field of antique silver and goldsmiths’ work. He is a trustee of the Wallace Collection and was recently Prime Warden of the Goldsmiths’ Company. He became chairman of PCRC in 2008.
Mr Geoffrey Bowman
Before joining the board of PCRC, in 2010 Geoffrey Bowman set up and is the chairman of the biennal Horizon Dinner Committee. His business life of forty years was spent in stockbroking in the city of London with L. Messel, Schroder Securities and Peel Hunt. He was diagnosed with Prostate Cancer in 2004 and is now retired.
Professor Prokar Dasgupta
Prokar is a Professor of Urology, leading academic urology at Guy's Hospital, King's College London. He has over 700 publications and a team of clinician-scientists developing novel robotics for the delivery of new immunological therapies in prostate cancer. He is credited with the "Dasgupta technique" of injecting Botulinum toxin in overactive bladders. Professor Dasgupta is the Editor-in-Chief of the BJUI. He was awarded the Golden Telescope by BAUS for a significant and lasting contribution to urology.
Sir Robert Francis
Sir Robert Francis QC is a barrister specialising in medical law and has been a Queen’s Counsel since 1992. He has chaired several healthcare related inquiries, including the Mid-Staffordshire NHS Foundation Trust Public Inquiry. He is a non-executive director of the Care Quality Commission, President of the Patients Association, and a Patron of the Florence Nightingale Foundation. He was knighted in 2014 for services to healthcare and patients.
Mrs Michele Hunter
Michele has been actively involved in the charity sector for nearly 30 years. She has been instrumental in raising over £10m for The October Club, she was Trustee of Children’s Liver Disease Foundation for 17 years and has managed high profile fundraising events for The Royal Hospital Chelsea, the Prostate Cancer Research Centre and others.
Mr Christopher Miller
Following an MA at Oxford, Christopher qualified as a chartered accountant with Coopers & Lybrand. After being an Associate Director at Hanson he joined the board of Wassall as CEO, before becoming Chairman of Melrose in 2003. Christopher is married with three children. He was diagnosed with prostate cancer in 2006.
Mr Ben Munro-Davies
Ben Munro-Davies is a TV journalist currently working for Sky News. He previously worked at the BBC and Channel 4 News.
Mr Shaun Grady
Shaun Grady is Vice-President Business Development Operations at AstraZeneca.
His career background includes roles at ICI, Zeneca, and AstraZeneca in Corporate, Pharmaceuticals and US Legal departments, HR and Business Development.
Shaun has worked on major projects including the AstraZeneca merger, creation of Avecia and Syngenta, acquisition of Cambridge Antibody Technology (CAT), MedImmune and Amylin, and the spin out of Albireo.